Access cutting-edge breast cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase IIa trial studies the side effects of abemaciclib monotherapy in treating patients age 70 years and older with hormone receptor positive, HER2 negative breast cancer that has spread to other places in the body.
Sponsor: City of Hope Medical Center
Check if you qualify for this breast cancer clinical trial in Boston, MA
If you're searching for breast cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.